TERN Stock Summary and Trading Ideas (Terns Pharmaceuticals | NASDAQ:TERN)

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Terns Pharmaceuticals trades on the NASDAQ stock market under the symbol TERN.

As of March 25, 2026, TERN stock price climbed to $52.86 with 51,502,321 million shares trading.

TERN has a beta of 1.09, meaning it tends to be more sensitive to market movements. TERN has a correlation of 0.03 to the broad based SPY ETF.

TERN has a market cap of $5.75 billion. This is considered a Mid Cap stock.

In the last 3 years, TERN traded as high as $52.98 and as low as $1.87.

The top ETF exchange traded funds that TERN belongs to (by Net Assets): VTI, IWM, IWN, VXF, IBB.

TERN has outperformed the market in the last year with a price return of +1406.0% while the SPY ETF gained +15.7%. TERN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +24.7% and +16.7%, respectively, while the SPY returned -4.6% and -2.7%, respectively.

TERN support price is $48.10 and resistance is $51.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TERN shares will trade within this expected range on the day.